Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Transient CDK9 Inhibition with AZD4573 Effectively Induces Apoptosis in Burkitt Lymphoma As a Monotherapy in Pre-Clinical Models

Danielle S Potter, India Ott, Jamal Saeh, Stephen Fawell, Lisa Drew, Justine Roderick-Richardson

Blood (2023) 142 (Supplement 1): 5013.

https://doi.org/10.1182/blood-2023-189128

Published: 2023

Journal Articles

AZD4573 in Combination with CHOP Increases Combination Benefit in Preclinical Peripheral T-Cell Lymphomas Models

Danielle S Potter, India Ott, Jamal Saeh, Richard Olsson, Stephen Fawell, Lisa Drew, Justine Roderick-Richardson

Blood (2023) 142 (Supplement 1): 7133.

https://doi.org/10.1182/blood-2023-179419

Published: 2023

Journal Articles

Elongator Complex Regulates MCL1 Dependency Via IRE1-XBP1 Axis of the ER Stress Response Pathway in Multiple Myeloma

Neeraj K Aryal, Anjana Sundarrajan, Scott Boiko, David Jenkins, Huayang Liu, Miika Ahdesmaki, Aurelie Bornot, Andrew Jarnuczak, Eric Miele, Ultan McDermott, Stephen Fawell, Lisa Drew, Larry H. Boise, Justin Cidado

Blood (2021) 138 (Supplement 1): 2275.

https://doi.org/10.1182/blood-2021-151194

Published: 2021

Journal Articles

Efficacy of Panobinostat (LBH589) in CTCL Cell Lines and a Murine Xenograft Model: Defining Molecular Pathways of Panobinostat Activity in CTCL.

Wenlin Shao, PhD, Joseph D. Growney, PhD, Yun Feng, MSc, Gregory O’Connor, MSc, Minying Pu, MD, Yung-Mae Yao, PhD, Paul Kwon, BS, Stephen Fawell, PhD, Peter Atadja, PhD

Blood (2007) 110 (11): 1375.

https://doi.org/10.1182/blood.V110.11.1375.1375

Published: 2007

Journal Articles

Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.

Joseph D. Growney, PhD, Peter Atadja, PhD, Wenlin Shao, PhD, Youzhen Wang, PhD, Minying Pu, MD, Brant Firestone, BS, Jane Cheng, MS, Colleen Kowal, BS, Christine Miller, BS, Joseph Eckman, BS, Yung-Mae Yao, PhD, Stephen Fawell, PhD, Andrew Spencer, MD, Jesus F. San Miguel, MD, Kenneth C. Anderson, MD

Blood (2007) 110 (11): 1510.

https://doi.org/10.1182/blood.V110.11.1510.1510

Published: 2007

NARROW

Transient CDK9 Inhibition with AZD4573 Effectively Induces Apoptosis in Burkitt Lymphoma As a Monotherapy in Pre-Clinical Models

AZD4573 in Combination with CHOP Increases Combination Benefit in Preclinical Peripheral T-Cell Lymphomas Models

Elongator Complex Regulates MCL1 Dependency Via IRE1-XBP1 Axis of the ER Stress Response Pathway in Multiple Myeloma

Efficacy of Panobinostat (LBH589) in CTCL Cell Lines and a Murine Xenograft Model: Defining Molecular Pathways of Panobinostat Activity in CTCL.

Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Transient CDK9 Inhibition with AZD4573 Effectively Induces Apoptosis in Burkitt Lymphoma As a Monotherapy in Pre-Clinical Models

AZD4573 in Combination with CHOP Increases Combination Benefit in Preclinical Peripheral T-Cell Lymphomas Models

Elongator Complex Regulates MCL1 Dependency Via IRE1-XBP1 Axis of the ER Stress Response Pathway in Multiple Myeloma

Efficacy of Panobinostat (LBH589) in CTCL Cell Lines and a Murine Xenograft Model: Defining Molecular Pathways of Panobinostat Activity in CTCL.

Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only